Abstract: A J-Pole antenna disclosed including: shunt segment extending out of the plane of the J-Pole antenna. A shunt segment extending out of the plane of the J-pole antenna aids in attaching the antenna to a connector and allowing for a reduction in the size of the antenna and connector. The shunt segment also makes the antenna shorter while preserving the same gain and impedance performance as a conventional J-Pole antenna. A connector plate and connector may be used with the antenna having the shunt segment extending out of the plane of the J-Pole antenna. A protective enclosure may be used with the J-Pole antenna and allowing a radiating antenna segment of the J-Pole antenna to extend from the protective enclosure.

Abstract: A J-Pole antenna disclosed including: shunt segment extending out of the plane of the J-Pole antenna. A shunt segment extending out of the plane of the J-pole antenna aids in attaching the antenna to a connector and allowing for a reduction in the size of the antenna and connector. The shunt segment also makes the antenna shorter while preserving the same gain and impedance performance as a conventional J-Pole antenna. A connector plate and connector may be used with the antenna having the shunt segment extending out of the plane of the J-Pole antenna. A protective enclosure may be used with the J-Pole antenna and allowing a radiating antenna segment of the J-Pole antenna to extend from the protective enclosure.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease Also disclosed pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: Disclosed are compounds which inhibit ?-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits ?-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Abstract: The present invention provides a glass packing tube for use in fabricating a microchannel plate. The glass tube has a plurality of flat inner surfaces and is used to form a boule including a plurality of optical fibers located in the tube and a plurality of support rods between the first optical fibers and the flat surfaces whereby the tube, fibers and rods are fused together with reduced glass flow.

Abstract: A display assembly that includes a flat panel display and a display stand. A hinge that attaches to the housing of the display provides for tilt adjustment. The display stand includes two rails that attach to a base and a sliding frame that is coupled to the hinge. The two rails support the sliding frame such that the sliding frame can move up and down along the two rails. A rotary dampener dampens downward movement of the sliding frame. The display stand also includes a latching mechanism that selectively latches the sliding frame to one of the rails. The latching mechanism includes a handle that can be manually operated so as to selectively engage and disengage the latching mechanism. Movement of the handle of the latching mechanism releases the latching mechanism. The display can then be moved up or down as desired to accommodate the needs of a particular user. Once the display is positioned as desired, the release of the handle operates to engage the latching mechanism.

Abstract: An improved image intensifier tube has electrically operative components that include a photocathode having a photoemissive layer, a microchannel plate (MCP) having a conductive input surface and a conductive output surface, and a vacuum housing for retaining the photocathode, microchannel plate and a fiber optic inverter and screen within an evacuated environment. The fiber optic inverter has a circumferentially extending flange portion extending toward the housing to accommodate a sealing material which sealingly engages an inner surface of an output flange with the inverter flange portion to form an air impervious vacuum seal and where the output flange is supported by the fiber optic inverter flange portion. The improved intensifier includes a photocathode having a flat faceplate conductively engaging the photocathode along the entire surface of the faceplate.